Safilo Group S.p.A. SFL
MIL · Italy · Health Technology
€1.82+0.02 (+0.89%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Adjusted EBITDA margin jumps 9.4 points in Q2, while management signals North America recovery and invests tariff refunds in brand growth.
Despite slowing sales worldwide, the Italian eyewear group was supported by a refund of 22 million euros in the first half and cited positive sales trends in the third quarter of 2026.
Despite currency headwinds, the Italian eyewear group strengthened its portfolio, improved margins, and delivered solid cash generation in the first quarter.
Together, the U.S.-based Spy+ and Serengeti brands generated sales of about $39 million in 2025.
Safilo Group SpA (SAFLF) reports robust growth in adjusted net profit and free cash flow, despite revenue pressures from a weakening US dollar.
Safilo's management said it has the capacity to strengthen profitability in 2026, proposing a new share buyback program and citing minimal exposure to the Middle East market.
Sales performance in Asia-Pacific and Europe boosted revenues in the third quarter and first nine months of the year.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.